Phase 3 Clinical Trial Of Pfizer Covid-19 Vaccine Remains Highly Effective After Six Months

Video Credit: CBS4 Miami
Published on April 2, 2021 - Duration: 02:26s

Phase 3 Clinical Trial Of Pfizer Covid-19 Vaccine Remains Highly Effective After Six Months

CBS4's Hank Tester reports on how Pfizer confirmed this week that an ongoing Phase 3 clinical trial of its coronavirus vaccine remains highly effective for at least six months after the second dose.


You are here

Related videos from verified sources

75 children in the Baltimore area take part in Moderna vaccine clinical trail 02:42
Video credit: ABC 2 News WMAR - Published on April 30, 2021 

โ€˜Donโ€™t line up outside centres tomorrow, vaccines to come in 1-2 daysโ€™: Kejriwal 03:45
Video credit: HT Digital Content - Published on April 30, 2021 

Phase 3 vaccination drive to delay in Karnataka due to vaccine shortage 01:38
Video credit: ANI - Published on April 30, 2021 

You might like